S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
1907, 1929, 1998, 2007--and now 2023? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
1907, 1929, 1998, 2007--and now 2023? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
1907, 1929, 1998, 2007--and now 2023? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
1907, 1929, 1998, 2007--and now 2023? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
1907, 1929, 1998, 2007--and now 2023? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
1907, 1929, 1998, 2007--and now 2023? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
1907, 1929, 1998, 2007--and now 2023? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
1907, 1929, 1998, 2007--and now 2023? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
1907, 1929, 1998, 2007--and now 2023? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
1907, 1929, 1998, 2007--and now 2023? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
1907, 1929, 1998, 2007--and now 2023? (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
1907, 1929, 1998, 2007--and now 2023? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
NASDAQ:SELB

Selecta Biosciences (SELB) Earnings Date, Estimates & Call Transcripts

$1.06
+0.02 (+1.92%)
(As of 09/22/2023 ET)
Compare
Today's Range
$1.03
$1.07
50-Day Range
$1.02
$1.23
52-Week Range
$0.90
$1.99
Volume
406,831 shs
Average Volume
578,383 shs
Market Capitalization
$162.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.83

Earnings Summary

Upcoming
Earnings Date
Nov. 2Estimated
Actual EPS
(Aug. 17)
-$0.07 Beat By $0.05
Consensus EPS
(Aug. 17)
-$0.12
Skip Charts & View Estimated and Actual Earnings Data

SELB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SELB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Selecta Biosciences Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.23)($0.01)($0.13)
Q2 20233($0.23)($0.09)($0.15)
Q3 20233($0.19)($0.08)($0.12)
Q4 20233($0.24)$0.05($0.09)
FY 202312($0.89)($0.13)($0.49)
Q1 20241($0.08)($0.08)($0.08)
Q2 20241($0.06)($0.06)($0.06)
Q3 20241($0.05)($0.05)($0.05)
Q4 20241($0.06)($0.06)($0.06)
FY 20244($0.25)($0.25)($0.25)

SELB Earnings Date and Information

Selecta Biosciences last posted its quarterly earnings results on August 17th, 2023. The reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.05. The company earned $5.25 million during the quarter, compared to the consensus estimate of $9.90 million. Selecta Biosciences has generated ($0.22) earnings per share over the last year (($0.22) diluted earnings per share). Earnings for Selecta Biosciences are expected to grow in the coming year, from ($0.33) to ($0.07) per share. Selecta Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 2nd, 2023 based off prior year's report dates.

Selecta Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/2/2023
Estimated)
------- 
8/17/2023Q2 2023($0.12)($0.07)+$0.05($0.07)$9.90 million$5.25 million  
5/4/2023Q1 2023($0.08)($0.11)($0.03)($0.08)$14.60 million$5.94 million
3/2/2023Q4 2022($0.04)($0.03)+$0.01($0.10)$12.72 million$16.80 million    
11/3/2022Q3 2022$0.01($0.01)($0.02)$0.03$33.00 million$20.71 million    
8/4/2022Q2 2022($0.03)$0.06+$0.09$0.06$21.45 million$39.27 million      
5/5/2022Q1 2022($0.09)($0.07)+$0.02($0.22)$18.82 million$34.00 million      
3/10/2022Q4 2021($0.07)($0.04)+$0.03($0.11)$20.00 million$29.94 million    
11/8/2021Q3 2021($0.07)($0.16)($0.09)($0.16)$13.38 million$24.43 million    
8/11/2021Q2($0.12)$0.04+$0.16($0.08)$10.83 million$19.66 million    
5/12/2021Q1 2021($0.12)($0.22)($0.10)($0.22)$6.88 million$11.05 million    
3/10/2021Q4 2020($0.12)($0.14)($0.02)($0.14)$5.83 million$11.95 million  
11/5/2020Q3 2020($0.12)($0.09)+$0.03($0.09)$3.75 million$4.65 million  












Selecta Biosciences Earnings - Frequently Asked Questions

When is Selecta Biosciences's earnings date?

Selecta Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 2nd, 2023 based off last year's report dates. Learn more on SELB's earnings history.

Did Selecta Biosciences beat their earnings estimates last quarter?

In the previous quarter, Selecta Biosciences (NASDAQ:SELB) reported ($0.07) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.12) by $0.05. Learn more on analysts' earnings estimate vs. SELB's actual earnings.

How can I listen to Selecta Biosciences's earnings conference call?

The conference call for Selecta Biosciences's latest earnings report can be listened to online. Listen to Conference Call

How much revenue does Selecta Biosciences generate each year?

Selecta Biosciences (NASDAQ:SELB) has a recorded annual revenue of $110.78 million.

How much profit does Selecta Biosciences generate each year?

Selecta Biosciences (NASDAQ:SELB) has a recorded net income of $35.38 million. SELB has generated -$0.22 earnings per share over the last four quarters.

What is Selecta Biosciences's EPS forecast for next year?

Selecta Biosciences's earnings are expected to grow from ($0.33) per share to ($0.07) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:SELB) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -